ISP reports Q1 net profit of $6.03 million

June 6, 2023

 

ISP Finance Services Limited (ISP) for the three months ended March 31, 2023:

Net interest income marginally increased to $97.14 million (2022: $97.43 million) after interest expenses increased 93% to $13.77 million (2022: $7.12 million) and total interest income increased 6% to $110.91 million (2022: $104.55 million). Management noted that the increase in interest expenses was due to the successful additional debt raise secured in October 2022 to facilitate future expansion plans.

Gross profit declined 2% to $92 million (2022: $93.73 million) following an increase of 39% in commission expense on loans, which closed at $5.14 million (2022: $3.70 million).

Total operating expenses increased 2% to $85.19 million (2022: $83.50 million) despite the 29% decline in allowance for credit loss to $28.11 million (2022: $24 million) as other operating expenses increased 24% to $34.41 million (2022: $27.83 million).

Consequently, profit before taxation declined 33% to $6.89 million (2022: $10.23 million).

After taxation of $861,147 (2022: $1.28 million), net profit declined 33% to $6.03 million (2022: $8.95 million).

Earnings per share (EPS) amounted to $0.06 (2022: $0.09). The trailing twelve-month EPS amounted to $0.52. The number of shares outstanding used for this calculation was 105,000,000. ISP’s stock closed the trading period at a price of $26.29 on June 5, 2023 with a corresponding P/E ratio of 50.45x.

Balance Sheet Highlights:

Total assets as at March 31, 2023 increased 39% to $1.07 billion (2022: $773.81 million). The major contributors to this movement were ‘Cash & cash equivalents’, which increased 278% to $206.69 million (2022: $54.65 million) and ‘Loans, net of provisions for credit losses’, which increased 16% to $789.51 million (2022: $679.48 million).

Shareholders’ equity as at March 31, 2023 increased 12% to $526.80 million (2022: $472.09 million), resulting in a book value per share of $5.02 (2022: $4.50).

 

Disclaimer:

Analyst Certification – The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.

Company Disclosure – The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.

More Stories from the Market
shutterstock_609342323
March 25, 2026   Sagicor Group Jamaica Limited (SJ) has declared a dividend of $0.89 per stock unit payable on May 6, 2026, to stockholders…
shutterstock_148562033
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that a senior officer purchased 276,992 PJAM shares on March 24, 2026. &…
shutterstock_453968572
March 25, 2026   Pan Jamaica Group Limited (PJAM) has advised that on March 24, 2026, three Directors were issued a total of 50,634 PJAM sh…
shutterstock_148562033
March 25, 2026   Supreme Ventures Limited (SVL) has advised that on March 17, 2026, a Director purchased 319,424 SVL shares and a related e…
shutterstock_148562033
March 25, 2026   IronRock Insurance Company Limited (ROC) has advised that connected parties sold a total of 70,939 ROC shares during the p…
shutterstock_453968572
March 25, 2026 United States: US Import Prices Jumped by the Most Since 2022 Ahead of War   The cost of imports into the US jumped in Febr…
shutterstock_537598660
March 24, 2026 Indies Pharma Jamaica Limited (INDIES) Unaudited financials for the first quarter ended January 31, 2026: Indies Pharma Jama…
shutterstock_609342323
March 24, 2026   Indies Pharma Jamaica Limited (INDIES) has declared an interim dividend of $0.135 per stock unit payable on April 30, 2026…